Exome Sequencing in Individuals with Isolated Biliary Atresia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 02 2020
Historique:
received: 26 07 2019
accepted: 22 01 2020
entrez: 19 2 2020
pubmed: 19 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

Biliary atresia (BA) is a severe pediatric liver disease resulting in necroinflammatory obliteration of the extrahepatic biliary tree. BA presents within the first few months of life as either an isolated finding or with additional syndromic features. The etiology of isolated BA is unknown, with evidence for infectious, environmental, and genetic risk factors described. However, to date, there are no definitive causal genes identified for isolated BA in humans, and the question of whether single gene defects play a major role remains open. We performed exome-sequencing in 101 North American patients of European descent with isolated BA (including 30 parent-child trios) and considered several experimental designs to identify potentially deleterious protein-altering variants that may be involved in the disease. In a case-only analysis, we did not identify genes with variants shared among more than two probands, and burden tests of rare variants using a case-case control design did not yield significant results. In the trio analysis of 30 simplex families (patient and parent trios), we identified 66 de novo variants in 66 genes including potentially deleterious variants in STIP1 and REV1. STIP1 is a co-chaperone for the heat-shock protein, HSP90, and has been shown to have diverse functions in yeast, flies and mammals, including stress-responses. REV1 is known to be a key player in DNA repair pathway and to interact with HSP90. In conclusion, our results do not support the hypothesis that a simple genetic model is responsible for the majority of cases of isolated BA. Our finding of de novo variants in genes linked to evolutionarily conserved stress responses (STIP1 and REV1) suggests that exploration of how genetic susceptibility and environmental exposure may interact to cause BA is warranted.

Identifiants

pubmed: 32066793
doi: 10.1038/s41598-020-59379-4
pii: 10.1038/s41598-020-59379-4
pmc: PMC7026070
doi:

Substances chimiques

HSP90 Heat-Shock Proteins 0
Heat-Shock Proteins 0
STIP1 protein, human 0
Nucleotidyltransferases EC 2.7.7.-
REV1 protein, human EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2709

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK062497
Pays : United States

Références

Schwarz, K. B. et al. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study. Hepatology 58, 1724–1731, https://doi.org/10.1002/hep.26512 (2013).
doi: 10.1002/hep.26512 pubmed: 23703680 pmcid: 3844083
Lakshminarayanan, B. & Davenport, M. Biliary atresia: A comprehensive review. J. Autoimmun. 73, 1–9, https://doi.org/10.1016/j.jaut.2016.06.005 (2016).
doi: 10.1016/j.jaut.2016.06.005 pubmed: 27346637
Gunasekaran, T. S., Hassall, E. G., Steinbrecher, U. P. & Yong, S. L. Recurrence of extrahepatic biliary atresia in two half sibs. Am. J. Med. Genet. 43, 592–594, https://doi.org/10.1002/ajmg.1320430317 (1992).
doi: 10.1002/ajmg.1320430317 pubmed: 1605254
Strickland, A. D., Shannon, K. & Coln, C. D. Biliary atresia in two sets of twins. J. pediatrics 107, 418–420 (1985).
doi: 10.1016/S0022-3476(85)80523-0
Lachaux, A. et al. Familial extrahepatic biliary atresia. J. pediatric gastroenterology Nutr. 7, 280–283 (1988).
doi: 10.1097/00005176-198803000-00020
Tsai, E. A. et al. Heterozygous deletion of FOXA2 segregates with disease in a family with heterotaxy, panhypopituitarism, and biliary atresia. Hum. Mutat. 36, 631–637, https://doi.org/10.1002/humu.22786 (2015).
doi: 10.1002/humu.22786 pubmed: 25765999 pmcid: 4477513
Davit-Spraul, A., Baussan, C., Hermeziu, B., Bernard, O. & Jacquemin, E. CFC1 gene involvement in biliary atresia with polysplenia syndrome. J. pediatric gastroenterology Nutr. 46, 111–112, https://doi.org/10.1097/01.mpg.0000304465.60788.f4 (2008).
doi: 10.1097/01.mpg.0000304465.60788.f4
Jacquemin, E., Cresteil, D., Raynaud, N. & Hadchouel, M. CFCI gene mutation and biliary atresia with polysplenia syndrome. J. pediatric gastroenterology Nutr. 34, 326–327 (2002).
doi: 10.1097/00005176-200203000-00026
Cui, S., Erlichman, J., Russo, P., Haber, B. A. & Matthews, R. P. Intrahepatic biliary anomalies in a patient with Mowat-Wilson syndrome uncover a role for the zinc finger homeobox gene zfhx1b in vertebrate biliary development. J. pediatric gastroenterology Nutr. 52, 339–344, https://doi.org/10.1097/MPG.0b013e3181ff2e5b (2011).
doi: 10.1097/MPG.0b013e3181ff2e5b
Ware, S. M. et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am. J. Hum. Genet. 74, 93–105, https://doi.org/10.1086/380998 (2004).
doi: 10.1086/380998 pubmed: 14681828
Kotalova, R. et al. Hepatic phenotypes of HNF1B gene mutations: a case of neonatal cholestasis requiring portoenterostomy and literature review. World J. Gastroenterol. 21, 2550–2557, https://doi.org/10.3748/wjg.v21.i8.2550 (2015).
doi: 10.3748/wjg.v21.i8.2550 pubmed: 25741167 pmcid: 4342936
Berauer, J. P. et al. Identification of PKD1L1 Gene Variants in Biliary Atresia Patients with Structural Malformations (BASM). AASLD 2017 (2017).
Uemura, M. et al. Sox17 haploinsufficiency results in perinatal biliary atresia and hepatitis in C57BL/6 background mice. Dev. 140, 639–648, https://doi.org/10.1242/dev.086702 (2013).
doi: 10.1242/dev.086702
Krupczak-Hollis, K. et al. The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev. Biol. 276, 74–88, https://doi.org/10.1016/j.ydbio.2004.08.022 (2004).
doi: 10.1016/j.ydbio.2004.08.022 pubmed: 15531365
Shimadera, S. et al. The inv mouse as an experimental model of biliary atresia. J. pediatric Surg. 42, 1555–1560, https://doi.org/10.1016/j.jpedsurg.2007.04.018 (2007).
doi: 10.1016/j.jpedsurg.2007.04.018
Clotman, F. et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Dev. 129, 1819–1828 (2002).
Garcia-Barcelo, M. M. et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum. Mol. Genet. 19, 2917–2925, https://doi.org/10.1093/hmg/ddq196 (2010).
doi: 10.1093/hmg/ddq196 pubmed: 20460270 pmcid: 2893814
Leyva-Vega, M. et al. Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3. Am. J. Med. Genet. A 152A, 886–895, https://doi.org/10.1002/ajmg.a.33332 (2010).
doi: 10.1002/ajmg.a.33332 pubmed: 20358598 pmcid: 2914625
Chen, Y. et al. A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1. Plos Genet. 14, e1007532, https://doi.org/10.1371/journal.pgen.1007532 (2018).
doi: 10.1371/journal.pgen.1007532 pubmed: 30102696 pmcid: 6107291
Ningappa, M. et al. The Role of ARF6 in Biliary Atresia. PLoS one 10, e0138381, https://doi.org/10.1371/journal.pone.0138381 (2015).
doi: 10.1371/journal.pone.0138381 pubmed: 26379158 pmcid: 4574480
Cui, S. et al. Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene. Gastroenterology 144, 1107–1115.e1103, https://doi.org/10.1053/j.gastro.2013.01.022 (2013).
doi: 10.1053/j.gastro.2013.01.022 pubmed: 23336978 pmcid: 3736559
Kaewkiattiyot, S., Honsawek, S., Vejchapipat, P., Chongsrisawat, V. & Poovorawan, Y. Association of X-prolyl aminopeptidase 1 rs17095355 polymorphism with biliary atresia in Thai children. Hepatol. Res. 41, 1249–1252, https://doi.org/10.1111/j.1872-034X.2011.00870.x (2011).
doi: 10.1111/j.1872-034X.2011.00870.x pubmed: 22118303
Tsai, E. A. et al. Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia. Hum. Genet. 133, 235–243, https://doi.org/10.1007/s00439-013-1368-2 (2014).
doi: 10.1007/s00439-013-1368-2 pubmed: 24104524
Green, R. C. et al. Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am. J. Hum. Genet. 99, 246, https://doi.org/10.1016/j.ajhg.2016.06.002 (2016).
doi: 10.1016/j.ajhg.2016.06.002 pubmed: 27392080 pmcid: 5005464
Kelsen, J. R. et al. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease. Gastroenterology 149, 1415–1424, https://doi.org/10.1053/j.gastro.2015.07.006 (2015).
doi: 10.1053/j.gastro.2015.07.006 pubmed: 26193622 pmcid: 4853027
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinforma. 26, 589–595, https://doi.org/10.1093/bioinformatics/btp698 (2010).
doi: 10.1093/bioinformatics/btp698
Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinforma. 43, 11.10.11–33, https://doi.org/10.1002/0471250953.bi1110s43 (2013).
doi: 10.1002/0471250953.bi1110s43
Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly. 6, 80–92, https://doi.org/10.4161/fly.19695 (2012).
doi: 10.4161/fly.19695 pubmed: 22728672 pmcid: 3679285
Karczewski, K. J. et. al. The Genome Aggregation Database Consortium Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. Preprint at, https://doi.org/10.1101/531210 (2019).
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315, https://doi.org/10.1038/ng.2892 (2014).
doi: 10.1038/ng.2892 pubmed: 24487276 pmcid: 3992975
Paila, U., Chapman, B. A., Kirchner, R. & Quinlan, A. R. GEMINI: integrative exploration of genetic variation and genome annotations. Plos computational biology 9, e1003153, https://doi.org/10.1371/journal.pcbi.1003153 (2013).
doi: 10.1371/journal.pcbi.1003153
Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinforma. 30, 2843–2851, https://doi.org/10.1093/bioinformatics/btu356 (2014).
doi: 10.1093/bioinformatics/btu356
Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nat. 536, 285–291, https://doi.org/10.1038/nature19057 (2016).
doi: 10.1038/nature19057
Pedersen, B. S. & Quinlan, A. R. Who’s Who? Detecting and Resolving Sample Anomalies in Human DNA Sequencing Studies with Peddy. Am. J. Hum. Genet. 100, 406–413, https://doi.org/10.1016/j.ajhg.2017.01.017 (2017).
doi: 10.1016/j.ajhg.2017.01.017 pubmed: 28190455 pmcid: 5339084
Genomes Project, C. et al. A global reference for human genetic variation. Nat. 526, 68–74, https://doi.org/10.1038/nature15393 (2015).
doi: 10.1038/nature15393
Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinforma. 26, 2867–2873, https://doi.org/10.1093/bioinformatics/btq559 (2010).
doi: 10.1093/bioinformatics/btq559
Fromer, M. & Purcell, S. M. Using XHMM Software to Detect Copy Number Variation in Whole-Exome Sequencing Data. Curr. Protoc. Hum. Genet. 81, 7 23 21–21, https://doi.org/10.1002/0471142905.hg0723s81 (2014).
doi: 10.1002/0471142905.hg0723s81
MacDonald, J. R., Ziman, R., Yuen, R. K., Feuk, L. & Scherer, S. W. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic acids Res. 42, D986–992, https://doi.org/10.1093/nar/gkt958 (2014).
doi: 10.1093/nar/gkt958 pubmed: 24174537
Ruderfer, D. M. et al. Patterns of genic intolerance of rare copy number variation in 59,898 human exomes. Nat. Genet. 48, 1107–1111, https://doi.org/10.1038/ng.3638 (2016).
doi: 10.1038/ng.3638 pubmed: 27533299 pmcid: 5042837
Casper, J. et al. The UCSC Genome Browser database: 2018 update. Nucleic acids Res. 46, D762–D769, https://doi.org/10.1093/nar/gkx1020 (2018).
doi: 10.1093/nar/gkx1020 pubmed: 29106570
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic acids Res. 44, W90–97, https://doi.org/10.1093/nar/gkw377 (2016).
doi: 10.1093/nar/gkw377 pubmed: 27141961 pmcid: 4987924
Li, B. & Leal, S. M. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am. J. Hum. Genet. 83, 311–321, https://doi.org/10.1016/j.ajhg.2008.06.024 (2008).
doi: 10.1016/j.ajhg.2008.06.024 pubmed: 18691683 pmcid: 2842185
Zhan, X., Hu, Y., Li, B., Abecasis, G. R. & Liu, D. J. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinforma. 32, 1423–1426, https://doi.org/10.1093/bioinformatics/btw079 (2016).
doi: 10.1093/bioinformatics/btw079
Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175–191 (2007).
doi: 10.3758/BF03193146
Lorent, K. et al. Identification of a plant isoflavonoid that causes biliary atresia. Sci. Transl. Med. 7, 286RA267, https://doi.org/10.1126/scitranslmed.aaa1652 (2015).
doi: 10.1126/scitranslmed.aaa1652
Zhao, X. et al. Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology 64, 894–907, https://doi.org/10.1002/hep.28603 (2016).
doi: 10.1002/hep.28603 pubmed: 27102575 pmcid: 5251204
Bamshad, M. J. et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745–755, https://doi.org/10.1038/nrg3031 (2011).
doi: 10.1038/nrg3031 pubmed: 21946919
Do, R. et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nat. 518, 102–106, https://doi.org/10.1038/nature13917 (2015).
doi: 10.1038/nature13917
Lange, L. A. et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233–245, https://doi.org/10.1016/j.ajhg.2014.01.010 (2014).
doi: 10.1016/j.ajhg.2014.01.010 pubmed: 24507775 pmcid: 3928660
Dong, R. et al. Identification of HSP90 as potential biomarker of biliary atresia using two-dimensional electrophoresis and mass spectrometry. PLoS one 8, e68602, https://doi.org/10.1371/journal.pone.0068602 (2013).
doi: 10.1371/journal.pone.0068602 pubmed: 23874684 pmcid: 3708914
Pozo, F. M. et al. Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis. Mol. Cell Biol. 31, 3396–3409, https://doi.org/10.1128/MCB.05117-11 (2011).
doi: 10.1128/MCB.05117-11 pubmed: 21690293
Xiao, Z et. al. Protein Quality Control is a Risk Factor and Therapeutic Target in Toxin-Induced Biliary Atresia. Preprint at https://doi.org/10.1101/821967 (2019).
Conrad, D. F. et al. Variation in genome-wide mutation rates within and between human families. Nat. Genet. 43, 712–714, https://doi.org/10.1038/ng.862 (2011).
doi: 10.1038/ng.862 pubmed: 21666693 pmcid: 3322360

Auteurs

Ramakrishnan Rajagopalan (R)

Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Ellen A Tsai (EA)

Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Genomics and Computational Biology Graduate Group, The University of Pennsylvania, Philadelphia, PA, USA.
Genetic Epidemiology Group, Department of Translational Biology, Biogen, Cambridge, MA, USA.

Christopher M Grochowski (CM)

Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.

Susan M Kelly (SM)

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Kathleen M Loomes (KM)

Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Nancy B Spinner (NB)

Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marcella Devoto (M)

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. devoto@email.chop.edu.
Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. devoto@email.chop.edu.
Department of Translational and Precision Medicine, University La Sapienza, Rome, Italy. devoto@email.chop.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH